Article
Cell Biology
Andrea Gutierrez Maria, Kleiton Silva Borges, R. C. P. Lira, Carolina Hassib Thome, Annabel Berthon, Ludivine Drougat, Katja Kiseljak-Vassiliades, Margaret E. Wierman, Fabio R. Faucz, Vitor Marcel Faca, Luiz Gonzaga Tone, Constantine A. Stratakis
Summary: A combination of aurora kinase inhibitor and beta-catenin pathway blocker showed decreased cell proliferation and viability in ACC cell lines, suggesting a potential combinatorial approach for targeting ACC tumors.
MOLECULAR AND CELLULAR ENDOCRINOLOGY
(2021)
Article
Medicine, General & Internal
Ting Hu, Xu Wang, Yun Xia, Lu Wu, Yuxi Ma, Rui Zhou, Yanxia Zhao
Summary: This study conducted systematic bioinformatics analysis and found that AURKA and AURKB were upregulated in breast cancer, and their high expression was associated with worse prognosis and immune cell infiltration. Furthermore, AURKA and AURKB were involved in multiple tumor-related signaling pathways. Therefore, they could serve as novel prognostic biomarkers or potential therapeutic targets for breast cancer.
CHINESE MEDICAL JOURNAL
(2022)
Article
Chemistry, Physical
Dong Zhao, Antal H. Kovacs, Michael Campbell, Wely Floriano, Jinqiang Hou
Summary: In this study, the selective binding mechanism of Barasertib, a ligand with high selectivity for Aurora kinase B over A, was investigated through molecular dynamics simulations and binding free energy analyses. The results showed that the hinge residue Arg159 in Aurora kinase B played a crucial role in Barasertib binding, and the binding interactions at the hydrophobic back pocket were important for the selectivity. The insights into the structural determinants of subtype selectivity will contribute to the development of selective Aurora kinase B inhibitors for cancer therapy.
JOURNAL OF MOLECULAR STRUCTURE
(2023)
Article
Chemistry, Medicinal
You-Guang Zheng, Jin-An Wang, Long Meng, Xin Pei, Ling Zhang, Lin An, Cheng-Lin Li, Ying-Long Miao
Summary: In this study, a series of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives were designed and evaluated for their biological activities, with compound 10e showing potential as a candidate for cancer therapy.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Cell Biology
You-Liang Lai, Kai-Hung Wang, Hsing-Pang Hsieh, Wan-Ching Yen
Summary: DBPR114 showed activity against HCC tumor cell proliferation in vitro regardless of p53 alteration status and tumor grade. It induced growth inhibition in HCC cells through apoptosis induction, cell cycle arrest, and polyploidy formation. DBPR114 also exhibited anti-angiogenic effects and significantly inhibited tumor growth in multiple HCC tumor xenograft models.
JOURNAL OF BIOMEDICAL SCIENCE
(2022)
Article
Evolutionary Biology
Jingchuan Xiao, Yingai Zhang
Summary: The study investigated the prognostic role of Aurora kinases in hepatocellular carcinoma (HCC) by analyzing their expression, overall survival data, promoter methylation level, and relationship with immunoinhibitors in patients from multiple databases. The results showed significant differences in mRNA expression, HCC stages, and overall survival of AURKA and AURKB in HCC tissues compared to control tissues. A hub module including AURKA, AURKB, and AURKC was identified within the protein-protein interaction network, and AURKB was suggested as a potential biomarker for HCC prognosis.
EVOLUTIONARY BIOINFORMATICS
(2021)
Review
Biochemistry & Molecular Biology
Dalila Boi, Elisabetta Rubini, Sara Breccia, Giulia Guarguaglini, Alessandro Paiardini
Summary: Myc transcription factors play crucial roles in many cellular processes and its overexpression is frequently associated with cancer. The interplay between Myc and kinases is essential for tumor cell proliferation, with kinase inhibitors showing potential for cancer treatment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Oncology
Keli Lima, Livia Bassani Lins de Miranda, Anali Del Milagro Bernabe Garnique, Bruna Oliveira de Almeida, Mariane Cristina do Nascimento, Guilherme Augusto Sousa Alcantara, Glaucia Maria Machado-Santelli, Eduardo Magalhaes Rego, Joao Agostinho Machado-Neto
Summary: AD80, a multikinase inhibitor, exhibits antineoplastic effects in pancreatic cancer cells by reducing cell viability and inducing mitotic aberrations, autophagy, and apoptosis. The drug also modulates several genes and signaling pathways, providing insights into potential therapeutic strategies for pancreatic cancer.
Article
Oncology
Camila Hirakata, Keli Lima, Bruna Oliveira De Almeida, Livia Bassani Lins De Miranda, Katharine Gurgel Dias Florencio, Luciana Costa Furtado, Leticia Veras Costa-Lotufo, Joao Agostinho Machado-Neto
Summary: The study showed that Reversine has significant anti-tumor effects on glioma cells, inducing mitotic catastrophe and apoptosis, especially in cells with high aurora kinase expression.
Article
Biology
Mohamed H. Elsherbeny, Usama M. Ammar, Magda H. Abdellattif, Mohammed A. S. Abourehab, Ahmed Abdeen, Samah F. Ibrahim, Doaa Abdelrahaman, Wessam Mady, Eun Joo Roh, Ahmed Elkamhawy
Summary: New quinazoline derivatives were designed with enhanced selectivity toward Aurora A. Compound 6e showed significant potency and selectivity, and further assays confirmed its potential as a lead compound for selective inhibition of Aurora A kinase with apoptosis properties.
Article
Chemistry, Medicinal
Simona Sestito, Andrea Bacci, Sara Chiarugi, Massimiliano Runfola, Francesca Gado, Eleonora Margheritis, Sheraz Gul, Maria E. Riveiro, Ramiro Vazquez, Samuel Huguet, Clementina Manera, Keyvan Rezai, Gianpiero Garau, Simona Rapposelli
Summary: Novel 2-oxindole-based derivatives were synthesized as dual PDK1-AurA kinase inhibitors, showing promising potential for treating Ewing sarcoma. Compound 12, the most potent one, is suitable for in vivo studies and presents nanomolar inhibitory potency against both PDK1 and AurA kinase.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Microbiology
Cindy Y. Ly, Jessica Pfannenstiel, Anil Pant, Zhilong Yang, Anthony R. Fehr, Maxim S. Rodzkin, David J. Davido
Summary: In this study, aurora kinase inhibitors were found to significantly reduce gene expression and viral replication of herpes simplex virus 1 (HSV-1). Furthermore, these inhibitors also showed inhibitory effects on the replication of other RNA and DNA viruses. These findings suggest a novel role for aurora kinases in the replication of diverse viruses.
MICROBIOLOGY SPECTRUM
(2023)
Review
Chemistry, Organic
Yogita Bansal, Richa Minhas, Ankit Singhal, Radhey Krishan Arora, Gulshan Bansal
Summary: Cancer is characterized by uncontrolled proliferation of cells and several key mediators such as EGF, IGF, PDGF, and FGF are involved in this process. Natural and synthetic anticancer compounds act by inhibiting enzymes and pathways responsible for the progression of tumor cells, but their main limitations are lack of specificity and normal cell toxicity.
CURRENT ORGANIC CHEMISTRY
(2021)
Review
Pharmacology & Pharmacy
Xueqing Hu, Xuan Liu, Ujjwol Khatri, Jie Wu
Summary: The aim of this study is to characterize the cancer cells that persist under continuous RET TKI treatment and identify the shared vulnerability of these cells. The results showed that MEK1/2 and Aurora kinase inhibitors were the most effective drugs when combined with a RET kinase inhibitor, leading to regression of the residual tumors.
DRUG RESISTANCE UPDATES
(2023)
Article
Chemistry, Physical
Zhiwei Ma, Sheng-You Huang, Fei Cheng, Xiaoqin Zou
Summary: Efficient ensemble docking algorithm is applied to dock ligands against multiple protein targets simultaneously. Using protein kinases as an example, the algorithm is shown to be effective in screening for inhibitors and investigating their selectivities for multiple target proteins.
JOURNAL OF PHYSICAL CHEMISTRY B
(2021)
Article
Multidisciplinary Sciences
Salma Batool, Shahid Ullah, Shahzadi Tabassum, Aishah Bilal, Amir Faisal, Rahman Shah Zaib Saleem, M. Sheeraz Ahmad
IRANIAN JOURNAL OF SCIENCE AND TECHNOLOGY TRANSACTION A-SCIENCE
(2019)
Article
Pharmacology & Pharmacy
Francesca L. Wood, Sam Shepherd, Angela Hayes, Manjuan Liu, Katia Grira, Yi Mok, Butrus Atrash, Amir Faisal, Vassilios Bavetsias, Spiros Linardopoulos, Julian Blagg, Florence Raynaud
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
(2019)
Article
Biochemistry & Molecular Biology
Sharon Riaz, Maheen Iqbal, Rahim Ullah, Rida Zahra, Ghayoor Abbas Chotana, Amir Faisal, Rahman Shah Zaib Saleem
BIOORGANIC CHEMISTRY
(2019)
Article
Cell Biology
Muhammad Furqan, Zille Huma, Zainab Ashfaq, Apsra Nasir, Rahim Ullah, Aishah Bilal, Maheen Iqbal, Muhammad Hashaam Khalid, Irshad Hussain, Amir Faisal
Article
Chemistry, Applied
Muhammad Sohail, Binish Ashfaq, Iqra Azeem, Amir Faisal, Sema Yiyit Dogan, Jianjun Wang, Hatice Duran, Basit Yameen
REACTIVE & FUNCTIONAL POLYMERS
(2019)
Article
Oncology
Simon J. Anderhub, Grace Wing-Yan Mak, Mark D. Gurden, Amir Faisal, Konstantinos Drosopoulos, Katie Walsh, Hannah L. Woodward, Paolo Innocenti, Isaac M. Westwood, Sebastien Naud, Angela Hayes, Efthymia Theofani, Simone Filosto, Harry Saville, Rosemary Burke, Rob L. M. van Montfort, Florence Raynaud, Julian Blagg, Swen Hoeder, Suzanne A. Eccles, Spiros Linardopoulos
MOLECULAR CANCER THERAPEUTICS
(2019)
Article
Pharmacology & Pharmacy
Mehwish Abid, Muhammad Naveed, Iqra Azeem, Amir Faisal, Muhammad Faizan Nazar, Basit Yameen
INTERNATIONAL JOURNAL OF PHARMACEUTICS
(2020)
Article
Multidisciplinary Sciences
Rida Zahra, Muhammad Furqan, Rahim Ullah, Aziz Mithani, Rahman Shah Zaib Saleem, Amir Faisal
Article
Cell & Tissue Engineering
Rahim Ullah, Ambreen Naz, Hafiza Sara Akram, Zakir Ullah, Muhammad Tariq, Aziz Mithani, Amir Faisal
STEM CELL RESEARCH & THERAPY
(2020)
Article
Plant Sciences
Haleema Sadia Malik, Aishah Bilal, Rahim Ullah, Maheen Iqbal, Sardraz Khan, Ishtiaq Ahmed, Karsten Krohn, Rahman Shah Zaib Saleem, Hidayat Hussain, Amir Faisal
JOURNAL OF NATURAL PRODUCTS
(2020)
Article
Biochemical Research Methods
Sidra Kanwal, Muhammad Naveed, Ali Arshad, Azka Arshad, Farhat Firdous, Amir Faisal, Basit Yameen
Summary: Novel reduction-sensitive polymer-drug conjugate (PDC) nanoparticles with precise drug release control exhibit significant cytotoxicity against cancer cells in vitro, highlighting their potential in tumor therapy.
BIOCONJUGATE CHEMISTRY
(2021)
Article
Chemistry, Multidisciplinary
Farhat Firdous, Rida Ibrahim, Muhammad Furqan, Hina Khan, Hadeeqa Raza, Upendra Singh, Abdul-Hamid Emwas, Mariusz Jaremko, Ghayoor Abbas Chotana, Amir Faisal, Rahman Shah Zaib Saleem
Summary: Griseofulvin derivatives showed activity in breast cancer cells, with the most promising compound characterized as a microtubule-stabilizing agent and also inhibiting proliferation of other cancer cells.
Article
Oncology
Muhammad Usama Tariq, Muhammad Furqan, Hira Parveen, Rahim Ullah, Muhammad Muddassar, Rahman Shah Zaib Saleem, Vassilios Bavetsias, Spiros Linardopoulos, Amir Faisal
Summary: The dual inhibitor CCT245718 has potent anti-proliferative activity against FLT3-ITD+ AML cell lines and binds strongly to FLT3-ITD and TKD (D835Y) mutants in vitro. It overcomes TKD-mediated resistance and inhibits both FLT3-ITD and Aurora A activities, leading to cell death through reduced phosphorylation of STAT5, downregulation of survivin, and induction of apoptosis.
BRITISH JOURNAL OF CANCER
(2021)
Article
Chemistry, Multidisciplinary
Mishal Amjad, Maheen Igbal, Amir Faisal, Arshad Mahmood Junjua, Irshad Hussain, Syed Zajif Hussain, Flamed A. Ghramh, Khalid Ali Khan, Hussnain Ahmed Janjua
NANOSCALE ADVANCES
(2019)
Article
Hematology
Andrew S. Moore, Amir Faisal, Grace W. Y. Mak, Farideh Miraki-Moud, Vassilios Bavetsias, Melanie Valenti, Gary Box, Albert Hallsworth, Alexis de Haven Brandon, Cristina P. R. Xavier, Randal Stronge, Andrew D. J. Pearson, Julian Blagg, Florence Raynaud, Rajesh Chopra, Suzanne A. Eccles, David C. Taussig, Spiros Linardopoulos
Article
Chemistry, Medicinal
Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan
Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang
Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman
Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li
Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang
Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla
Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)